VivaChek Diagnostics, Inc.

VivaChek Diagnostics, Inc. is a Sacramento, CA-based subsidiary of VivaChek Biotech, a global point-of-care testing (POCT) manufacturer established in 2013. The company specializes in blood glucose monitoring systems, drugs-of-abuse testing solutions, and related diagnostic devices. VivaChek operates globally across 120+ countries, offering OEM, ODM, and manufacturing services. Product lines include FDA-cleared blood glucose meters (including the VivaChek Link Plus 4G system with advanced FAD enzyme technology), multi-drug urine test cups, fentanyl-specific FIA test kits, and the BioSieve Toxismart FIA Reader platform. Recent FDA clearances include: three glucose meters (2024), BioSieve Fentanyl FIA Home Test Kit and Reader for OTC use (2024), VivaChek Link Plus 4G (2023), and Multi-Drug Urine Test Cup (2023). The company also manufactures lactate analyzers and multifunction monitoring systems. VivaChek maintains FDA 510(k) clearances and demonstrates commitment to quality and innovation through participation in major medical trade shows (Medica, FIME). The company serves workplace drug testing, clinical diagnostics, and home health monitoring markets.